Submitted on Tuesday 7th November 2017
Published on Monday 14th May 2018
Current status: Closed
Closed: Wednesday 14th November 2018
Signatures: 64
Tagged with
Full funding for Aflibercept, Bevacizumab,Lapatinib,Eribulin, Everolimus
Fewer signatures
More signatures
Colours relate to the distribution of signatures across different constituencies and not to the absolute number.
Constituency boundaries are slightly simplified in order to minimise loading time. More detailed boundaries are shown on individual constituency pages.
3.141.24.134 Sun, 28 Apr 2024 15:37:52 +0100
